Tag: Lower Price Target

Oracle (NYSE:ORCL – Get Free Report) had its price objective cut by equities researchers at Scotiabank from $260.00 to $220.00 in a report issued on Tuesday, MarketBeat.com reports. The firm presently has a “sector outperform” rating on the enterprise software provider’s stock. Scotiabank’s price target indicates a potential upside of 49.91% from the company’s previous close.

Other equities analysts have also issued reports about the stock. DA Davidson lowered their target price on shares of Oracle from $200.00 to $180.00 and set a “neutral” rating for the company in a report on Thursday, December 11th. Citigroup reaffirmed a “market outperform” rating on shares of Oracle in a research report on Wednesday, December 17th. Erste Group Bank downgraded Oracle from a “buy” rating to a “hold” rating in a report on Monday, November 10th. Evercore ISI raised their price target on Oracle from $350.00 to $385.00 and gave the company an “outperform” rating in a report on Friday, October 17th. Finally, Mizuho set a $400.00 price target on Oracle in a research report on Monday, December 15th. Three analysts have rated the stock with a Strong Buy rating, twenty-five have assigned a Buy rating, eleven have assigned a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $296.03.

Check Out Our Latest Stock Analysis on Oracle

Oracle Stock Performance

Shares of Oracle stock opened at $146.75 on Tuesday. Oracle has a 12 month low of $118.86 and a 12 month high of $345.72. The firm has a market capitalization of $421.63 billion, a P/E ratio of 27.58, a P/E/G ratio of 1.35 and a beta of 1.64. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 3.28. The business has a fifty day simple moving average of $191.31 and a two-hundred day simple moving average of $235.52.

Oracle (NYSE:ORCL – Get Free Report) last released its earnings results on Wednesday, December 10th. The enterprise software provider reported $2.26 earnings per share for the quarter, topping analysts’ consensus estimates of $1.64 by $0.62. Oracle had a net margin of 25.28% and a return on equity of 70.60%. The firm had revenue of $16.06 billion for the quarter, compared to the consensus estimate of $16.19 billion. During the same period in the prior year, the firm earned $1.47 EPS. The company’s revenue was up 14.2% compared to the same quarter last year. On average, equities analysts forecast that Oracle will post 5 earnings per share for the current fiscal year.

Insider Activity at Oracle

In other Oracle news, CEO Clayton M. Magouyrk sold 10,000 shares of the business’s stock in a transaction on Friday, December 19th. The shares were sold at an average price of $192.52, for a total transaction of $1,925,200.00. Following the completion of the sale, the chief executive officer directly owned 144,030 shares in the company, valued at approximately $27,728,655.60. The trade was a 6.49% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Mark Hura sold 15,000 shares of the stock in a transaction on Wednesday, December 24th. The shares were sold at an average price of $196.89, for a total value of $2,953,350.00. Following the transaction, the insider directly owned 234,077 shares in the company, valued at $46,087,420.53. The trade was a 6.02% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 62,223 shares of company stock valued at $12,136,764 over the last ninety days. Company insiders own 40.90% of the company’s stock.

Institutional Trading of Oracle

A number of hedge funds have recently bought and sold shares of ORCL. Winnow Wealth LLC purchased a new position in shares of Oracle in the second quarter worth approximately $28,000. FSA Wealth Management LLC purchased a new stake in Oracle during the third quarter valued at approximately $28,000. Joseph Group Capital Management bought a new position in Oracle in the fourth quarter worth approximately $29,000. Kilter Group LLC bought a new position in Oracle in the second quarter worth approximately $30,000. Finally, Darwin Wealth Management LLC boosted its stake in shares of Oracle by 130.0% during the 3rd quarter. Darwin Wealth Management LLC now owns 115 shares of the enterprise software provider’s stock worth $32,000 after acquiring an additional 65 shares during the last quarter. Hedge funds and other institutional investors own 42.44% of the company’s stock.

More Oracle News

Here are the key news stories impacting Oracle this week:

• Positive Sentiment: Oracle Health won a multi-organization pilot in Canada for its Clinical AI Agent, validating commercial traction for Oracle’s healthcare AI products. Multiple Canadian Healthcare Organizations Select Oracle Health Clinical AI Agent
• Positive Sentiment: Oracle’s recent $25B bond offering reportedly attracted heavy demand, indicating strong investor appetite for its debt and suggesting financing channels are open. Oracle Stock (ORCL) Gains as $25B Bond Offering Attracts Heavy Demand
• Positive Sentiment: Some sell-side firms (e.g., Barclays) have reiterated bullish ratings and high price targets, implying analysts still see upside if Oracle executes its AI/data-center strategy. Barclays Reiterates Overweight on Oracle
• Neutral Sentiment: Oracle announced an equity distribution agreement and senior notes issuance to fund its plans — this provides capital but increases near-term financing activity and complexity. Oracle Bolsters Financing with Major Senior Notes Issuance
• Neutral Sentiment: Oracle continues product and go-to-market pushes (AI banking platform, enterprise AI agents) that could drive long-term growth but require heavy near-term capex. Oracle Reimagines Banking for the AI Era
• Neutral Sentiment: Strategic commentary ties Oracle’s massive data-center and power plans to a structural shift (e.g., MarketBeat piece on companies funding power and SMRs); long-term strategic rationale exists but is execution- and timeline-dependent. The Atomic Pivot: AI’s $50 Billion Power Move
• Negative Sentiment: Markets punished Oracle after management outlined plans to raise roughly $45–50B for AI infrastructure (debt and equity), stoking dilution and leverage fears and sparking the recent sell-off. Oracle (ORCL) Is Down 11.6% After Unveiling a US$45–50 Billion AI Infrastructure Capital Plan
• Negative Sentiment: Multiple law firms have filed or are soliciting clients for securities class actions tied to Oracle’s disclosures (senior notes/offering documents and the June–Dec 2025 class period), adding legal risk and headline pressure. Kessler Topaz Files Securities Fraud Class Action Against Oracle
• Negative Sentiment: Reports say banks are exploring selling billions in loans tied to Oracle’s data centers and the company may cut up to 30,000 jobs — both raise execution and integration risks and amplify downside sentiment. Oracle Stock (ORCL) Slips as Banks Explore Selling Its Data Center Loans Oracle May Slash Up to 30,000 Jobs
• Negative Sentiment: Analysts have trimmed price targets (BMO, Scotiabank among them) and commentary highlights investor anxiety about the size/timing of the capital raise and AI execution — contributing to the stock’s decline. Oracle Price Target Lowered at BMO